- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.03. | Zomedica partners with Boehringer Ingelheim on equine testing | 7 | Investing.com | ||
| 18.03. | Zomedica Corp.: Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA Platform | 1.204 | ACCESS Newswire | Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue ANN ARBOR, MI / ACCESS Newswire... ► Artikel lesen | |
| 17.03. | Zomedica reports Q4 results | 5 | Seeking Alpha | ||
| 16.03. | Zomedica Corp.: Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity | 363 | ACCESS Newswire | Zomedica surpasses $10 million in quarterly revenue for the first time and delivers record year-over-year revenue for 20th straight quarter. ANN ARBOR, MI / ACCESS Newswire / March 16, 2026 / Zomedica... ► Artikel lesen | |
| 16.03. | Zomedica Corp. - 8-K, Current Report | 4 | SEC Filings | ||
| 16.03. | Zomedica Corp. - 10-K, Annual Report | 5 | SEC Filings | ||
| 10.03. | Zomedica Corp.: Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th "Fourth Friday at Four" Investor Webinar | 416 | ACCESS Newswire | Webinar will include a review of full-year 2025 and fourth quarter 2025 financial results, a deep dive into the equine veterinary market and Zomedica's equine-focused product portfolio, along with a... ► Artikel lesen | |
| ZOMEDICA Aktie jetzt für 0€ handeln | |||||
| 25.02. | Zomedica Corp.: Zomedica Expands Distribution of TRUVIEW Digital Microscopy Platform Through National Agreement with Moichor, a Leader in Veterinary Pathology | 1.410 | ACCESS Newswire | Partnership Expected to Accelerate System Placements and Support Recurring Consumables Revenue Growth ANN ARBOR, MI / ACCESS Newswire / February 25, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or... ► Artikel lesen | |
| 05.02. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline | 541 | ACCESS Newswire | February session to highlight how Zomedica's R&D strategy supports scalable growth and long-term shareholder value ANN ARBOR, MI / ACCESS Newswire / February 5, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen | |
| 23.01. | Zomedica Corp.: Zomedica Expands its TRUVIEW Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity | 1.041 | ACCESS Newswire | AI-enabled hematology and cytology analysis improves diagnostic speed, consistency, and workflow efficiency for veterinary clinics ANN ARBOR, MI / ACCESS Newswire / January 23, 2026 / Zomedica Corp.... ► Artikel lesen | |
| 22.01. | Zomedica Corp.: Zomedica Enters Contract Manufacturing and Services Agreement with Rahm Sensor Development to Expand Revenue Streams Beyond Animal Health | 431 | ACCESS Newswire | Agreement leverages existing infrastructure to add contract-based revenue, improve asset utilization, support long-term cash flow and create shareholder value through diversified markets ANN ARBOR,... ► Artikel lesen | |
| 14.01. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on January 23rd Focused on Digital Innovation & Technology-Driven Growth | 619 | ACCESS Newswire | January session to highlight Zomedica's expanding digital capabilities and long-term innovation strategy ANN ARBOR, MI / ACCESS Newswire / January 14, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen | |
| 30.12.25 | Zomedica Corp.: Zomedica Launches Next-Generation VETGuardian PLUS Monitor, Expanding Core Monitoring Platform in Growing Veterinary Market | 365 | ACCESS Newswire | New platform improves workflow efficiency, strengthens clinical confidence, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire / December 30, 2025 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| 11.12.25 | Zomedica Corp.: Zomedica Announces Collaboration with Prime Video as Assisi Loop Products Appear in New Holiday Film Merv | 472 | ACCESS Newswire | The collaboration highlights Zomedica's commitment to expanding pet wellness education as Assisi Loop technology is featured in the highly anticipated movie Merv now available on Prime Video ANN ARBOR... ► Artikel lesen | |
| 04.12.25 | Zomedica Corp.: Zomedica Expands TRUFORMA Diagnostic Menu with Launch of Equine Progesterone Assay | 397 | ACCESS Newswire | Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN ARBOR, MI / ACCESS Newswire / December 4, 2025 / Zomedica... ► Artikel lesen | |
| 24.11.25 | Zomedica steigert Umsatz um 16 %, verfehlt aber Gewinnprognose - Aktie legt dennoch kräftig zu | 9 | Investing.com Deutsch | ||
| 11.11.25 | Zomedica Corp.: Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review | 473 | ACCESS Newswire | November session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars ANN ARBOR, MI / ACCESS Newswire / November 11, 2025 / Zomedica... ► Artikel lesen | |
| 06.11.25 | Zomedica Corp.: Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential | 448 | ACCESS Newswire | Certification enhances global market readiness, reinforces quality systems, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire / November 6, 2025 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| 04.11.25 | Zomedica reports Q3 results | 4 | Seeking Alpha | ||
| 04.11.25 | Zomedica Corp.: Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth | 573 | ACCESS Newswire | Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter! ANN ARBOR, MI / ACCESS Newswire / November 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 36,780 | 0,00 % | EQS-DD: Siemens Healthineers AG: Dorothea Simon, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
20.03.2026 / 16:23... ► Artikel lesen | |
| FRESENIUS | 44,510 | 0,00 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
20.03.2026 / 09:22... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,400 | 0,00 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,220 | 0,00 % | Ihre wichtigsten Termine: Spannende Updates von: Fedex, Continental, Docmorris, Carl Zeiss Meditec und 1&1 | © Foto: Kevin Wolf - FR33460 APGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | |
| GERRESHEIMER | 20,760 | 0,00 % | Shortseller-Positionen aktuell: Auto1, pbb, Gerresheimer, Jenoptik, Lanxess, LEG Immobilien, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,540 | -2,24 % | Privia Health Group, Inc.: Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence | ||
| BRIGHTSPRING HEALTH SERVICES | 44,820 | 0,00 % | Brightspring-Aktie erreicht Rekordhoch von 44,88 USD | ||
| DRAEGERWERK | 93,10 | 0,00 % | Ihre wichtigsten Termine: Frische Zahlen von: Kingfisher, Drägerwerk & Bellway sowie neue Konjunkturdaten | © Foto: Axel Heimken - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:30... ► Artikel lesen | |
| BILLIONTOONE | 77,00 | +3,94 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| OTTOBOCK | 54,20 | 0,00 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock veröffentlicht Geschäftsbericht für 2025 | Vorläufige Zahlen bestätigt | Dividendenvorschlag von 0,97 Euro je Aktie | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): Jahresbericht
Ottobock veröffentlicht Geschäftsbericht für 2025 | Vorläufige Zahlen bestätigt | Dividendenvorschlag von 0,97... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 20,580 | -0,58 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Named Finalist for 2026 GeekWire "Deal of the Year" | ||
| ECKERT & ZIEGLER | 14,170 | 0,00 % | EQS-DD: Eckert & Ziegler SE: Dr. Harald Hasselmann, Zuteilung von 62.541 Aktien als Vergütungsbestandteil im Rahmen der Vorstandsvergütung (eigene Aktien des Emittenten). Es handelt sich um ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
24.03.2026 / 10:04... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 17,590 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| HEARTFLOW | 27,750 | 0,00 % | Heartflow stock price target raised to $43 by Canaccord on guidance | ||
| NEUROPACE | 13,530 | +2,11 % | BDMD: Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion | NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive... ► Artikel lesen |
ZOMEDICA CORP gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZOMEDICA CORP finden Sie auf Wallstreet Online.